DK1406902T3 - Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander - Google Patents

Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander

Info

Publication number
DK1406902T3
DK1406902T3 DK02744532T DK02744532T DK1406902T3 DK 1406902 T3 DK1406902 T3 DK 1406902T3 DK 02744532 T DK02744532 T DK 02744532T DK 02744532 T DK02744532 T DK 02744532T DK 1406902 T3 DK1406902 T3 DK 1406902T3
Authority
DK
Denmark
Prior art keywords
sup
hexahydroazepino
indolines
indoles
receptor ligands
Prior art date
Application number
DK02744532T
Other languages
Danish (da)
English (en)
Inventor
Arthur Glenn Romero
Jian-Min Fu
Jeanette Kay Morris
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1406902T3 publication Critical patent/DK1406902T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK02744532T 2001-07-13 2002-07-10 Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander DK1406902T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30530501P 2001-07-13 2001-07-13

Publications (1)

Publication Number Publication Date
DK1406902T3 true DK1406902T3 (da) 2006-01-30

Family

ID=23180257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02744532T DK1406902T3 (da) 2001-07-13 2002-07-10 Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander

Country Status (11)

Country Link
US (1) US7022694B2 (ja)
EP (1) EP1406902B1 (ja)
JP (1) JP2005522408A (ja)
AT (1) ATE307133T1 (ja)
BR (1) BR0211140A (ja)
CA (1) CA2452610A1 (ja)
DE (1) DE60206762T2 (ja)
DK (1) DK1406902T3 (ja)
ES (1) ES2250667T3 (ja)
MX (1) MXPA04000358A (ja)
WO (1) WO2003006466A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539704A1 (en) * 2002-08-20 2005-06-15 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
CN1688584A (zh) * 2002-08-29 2005-10-26 先灵公司 治疗肥胖和中枢神经系统疾病的选择性d1/d5受体拮抗剂
EA011011B1 (ru) 2004-02-25 2008-12-30 Эли Лилли Энд Компани 6-ЗАМЕЩЁННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-БЕНЗО[d]АЗЕПИНЫ В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ 5-HT
EP1792629A4 (en) 2004-08-25 2010-08-25 Takeda Pharmaceutical PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF
JP5237810B2 (ja) 2005-09-01 2013-07-17 イーライ リリー アンド カンパニー ５−ＨＴ２Ｃ受容体アゴニストとしての６−置換された２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
US7981882B2 (en) 2005-09-01 2011-07-19 Eli Lilly And Company 6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
DK1924561T3 (da) 2005-09-01 2012-12-10 Lilly Co Eli 6-arylalkylamino-2,3,4,5-tetrahydro-1h-benzo[d]azepiner as 5-ht2c-receptor agonister
PT1924560E (pt) 2005-09-01 2009-10-23 Lilly Co Eli 2,3,4,5-tetra-hidro-1h-benzo[d]azepinas como agonistas de receptores 5-ht2c
EP2018863B9 (en) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
JPWO2011071136A1 (ja) 2009-12-11 2013-04-22 アステラス製薬株式会社 線維筋痛症治療剤
CA2947300A1 (en) 2014-05-05 2015-11-12 Zhengbing Cao Antimicrobial surface coatings
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬
EP3753924A1 (en) * 2019-06-18 2020-12-23 AnaMar AB New tricyclic 5-ht2 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK26793D0 (da) 1993-03-10 1993-03-10 Novo Nordisk As Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling
AU687255B2 (en) 1994-09-14 1998-02-19 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
EP0973778A1 (en) 1997-03-07 2000-01-26 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
DE69922936T2 (de) 1998-03-31 2005-12-08 Neurosearch A/S Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi

Also Published As

Publication number Publication date
ATE307133T1 (de) 2005-11-15
US20030060458A1 (en) 2003-03-27
ES2250667T3 (es) 2006-04-16
EP1406902A1 (en) 2004-04-14
US7022694B2 (en) 2006-04-04
JP2005522408A (ja) 2005-07-28
CA2452610A1 (en) 2003-01-23
MXPA04000358A (es) 2004-05-04
BR0211140A (pt) 2005-10-25
DE60206762D1 (de) 2006-03-02
EP1406902B1 (en) 2005-10-19
WO2003006466A1 (en) 2003-01-23
DE60206762T2 (de) 2006-07-13

Similar Documents

Publication Publication Date Title
TW200613243A (en) Novel compounds
MXPA04000507A (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y uso terapeutico.
ATE316083T1 (de) Adamantanderivate
SE0103836D0 (sv) Novel compounds
AU2003228770A1 (en) Substituted pyrazolopyrimidines
HK1070054A1 (en) Arylsulfonyl derivatives with5-ht6 receptor affinity
SI1506185T1 (sl) Spojine in njihova uporaba kot inhibitorji 5-HT
DK1458713T3 (da) Indolinonderivater anvendelige som proteinkinaseinhibitorer
DK1406902T3 (da) Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
YU80902A (sh) Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže
SE0302139D0 (sv) Novel compounds
MY138826A (en) 2,7-substituted indoles
DE60208694D1 (de) Piperidinylmorpholinylderivate als modulatoren der aktivität des chemokinrezeptors
EP1617806A4 (en) SELECTIVE SPIROCYCLIC GLUCOCORTICOID RECEPTOR MODULATORS
WO2003097597A3 (fr) Derives d'indole et leur utilisation en tant que ligands des recepteurs cb2
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
IL188927A0 (en) Aryloxy quinolines and uses thereof as 5-ht6 modulators
ATE274515T1 (de) Pyrazolopyridinderivate
WO2003076426A3 (en) Pyridinyloxy derivatives as 5-ht receptor ligands
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten
MXPA04001201A (es) Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.